Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation

Food and Nutrition Research

Volumn 61, Issue 1, 2017, Pages

  Crescenzo, Raffaella ^a   Mazzoli, Arianna ^a   Di Luccia, Blanda ^a   Bianco, Francesca ^a   Cancelliere, Rosa ^a   Cigliano, Luisa ^a   Liverini, Giovanna ^a   Baccigalupi, Loredana ^a   Iossa, Susanna ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Fructose; Inflammation; Insulin; Microbiota; Obesity

Indexed keywords

ACONITATE HYDRATASE; ACYL COENZYME A DESATURASE; AMINOTRANSFERASE; ANTIBIOTIC AGENT; CERAMIDE; FATTY ACID; FRUCTOSE; INSULIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; OCCLUDIN; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CLOSTRIDIUM; CONTROLLED STUDY; DIETARY INTAKE; ENERGY BALANCE; ENZYME ACTIVITY; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; ILEUM; INFLAMMATION; INSULIN SIGNALING; INTESTINE FLORA; LIPID PEROXIDATION; LIVER; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; PLASMA; RAT; RUMINOCOCCUS; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

EID: 85028312224     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.1080/16546628.2017.1331657     Document Type: Article

References (50)

1. Dekker MJ, Su Q, Baker C, et al. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299(5):E685-E694.
2. Lyssiotis CA, Cantley LC. Metabolic syndrome: f stands for fructose and fat. Nature. 2013;502(7470):181-182.
3. Crescenzo R, Bianco F, Falcone I, et al. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr. 2013;52:537-545.
4. Crescenzo R, Bianco F, Coppola P, et al. Increased skeletal muscle mitochondrial efficiency in rats with fructose-induced alteration in glucose tolerance. Br J Nutr. 2013;110:1996-2003.
5. Crescenzo R, Bianco F, Coppola P, et al. Adipose tissue remodeling in rats exhibiting fructose-induced obesity. Eur J Nutr. 2014;53:413-419.
6. Crescenzo R, Bianco F, Coppola P, et al. Fructose supplementation worsens the deleterious effects of shortterm high fat feeding on hepatic steatosis and lipid metabolism in adult rats. Exp Physiol. 2014;99(9):1203-1213.
7. Crescenzo R, Bianco F, Coppola P, et al. The effect of high-fat-high-fructose diet on skeletal muscle mitochondrial energetics in adult rats. Eur J Nutr. 2015;54:183-192.
8. Serino M, Luche E, Gres S, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut. 2012;61:543-553.
9. Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev. 2012;13:799-809.
10. Di Luccia B, Crescenzo R, Mazzoli A, et al. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS One. 2015;10(8):e0134893.
11. Bergheim I, Weber S, Vos M, et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol. 2008;48(6):983-992.
12. Carvalho BM, Guadagnini D, Tsukumo DM, et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia. 2012;5(10):2823-2834.
13. Murphy EF, Cotter PD, Hogan A, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2013;62(2):220-226.
14. Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008;22(7):2416-2426.
15. Ferrier L, Berard F, Debrauwer L, et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol. 2006;168:1148-1154.
16. Cacho J, Sevillano J, de Castro J, et al. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol. 2008;295:E1269-E1276.
17. Abdul-Ghani MA, Matsuda M, Balas B, et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diab Care. 2008;30:89-94.
18. Fernandes MA, Custódio JB, Santos MS, et al. Tetrandrine concentrations not affecting oxidative phosphorylation protect rat liver mitochondria from oxidative stress. Mitochondrion. 2006;6:176-185.
19. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-510.
20. Crescenzo R, Bianco F, Falcone I, et al. Hepatic mitochondrial energetic during catch-up fat after caloric restriction. Metab. 2010;59:1221-1230.
21. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984;87:1344-1350.
22. Kim JJ, Shajib MS, Manocha MM, et al. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012;60:3678.
23. Crescenzo R, Bianco F, Falcone I, et al. Mitochondrial energetic in liver and skeletal muscle after energy restriction in young rats. Br J Nutr. 2012;108:655-665.
24. Cairns CB, Walther J, Harken AH, et al. Mitochondrial oxidative phosphorylation efficiencies reflect physiological organ roles. Am J Physiol. 1998;274:R1376-R1383.
25. Strittmatter P, Spatz L, Corcoran D, et al. Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci USA. 1974;71:4565-4569.
26. Gardner PR. Aconitase: sensitive target and measure of superoxide. Meth Enzymol. 2002;349:9-16.
27. Flohè L, Otting F. Superoxide dismutase assay. Meth Enzymol. 1974;105:93-104.
28. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460-2461.
29. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261-5267.
30. Caporaso JG, Bittinger K, Bushman FD, et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2010;26(2):266-267.
31. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069-5072.
32. Villegas I, de la Lastra CA, Orjales A, et al. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. Int Immunopharmacol. 2003;3:1731-1741.
33. Pagadala M, Kasumov T, McCullough AJ, et al. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012;23:365-371.
34. Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17:319-326.
35. Spruss A, Bergheim I. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem. 2009;20:657-662.
36. Spruss A, Kanuri G, Wagnerberger S, et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 2009;50:1094-1104.
37. Wagnerberger S, Spruss A, Kanuri G, et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr. 2012;107:1727-1738.
38. Sellmann C, Priebs J, Landmann M, et al. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J Nutr Biochem. 2015;26:1183-1192.
39. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23-46.
40. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416:15-18.
41. Mailloux RJ, Harper ME. Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med. 2011;51(6):1106-1115.
42. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50(5):567-575.
43. Bettaieb A, Vazquez Prieto MA, Rodriguez Lanzi C, et al. (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic Biol Med. 2014;72:247-256.
44. Kannappan S, Palanisamy N, Anuradha CV. Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats. Eur J Pharmacol. 2010;645(1-3):177-184.
45. Feillet-Coudray C, Fouret G, Ebabe Elle R, et al. The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol. Free Radic Res. 2014;48(10):1232-1246.
46. Duca FA, Sakar Y, Lepage P, et al. Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes. 2014;63:1624-1636.
47. Kim KA, Gu W, Lee IA, et al. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012;7(10):e47713.
48. Ferrer M, Ruiz A, Lanza F, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Env Microbiol. 2013;15(1):211-226.
49. Kasai C, Sugimoto K, Moritani I, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and nextgeneration sequencing. BMC Gastroenterol. 2015;15:100.
50. Lecomte V, Kaakoush NO, Maloney CA, et al. Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One. 2015;10(5):e0126931.